Institutional investors purchased a net $4.9 million shares of AEGR during the quarter ended June 2016, and now own 87.92% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
INVUS PUBLIC EQUITIES ADVISORS L... Bought 1.0 Million shares of Aegerion Pharmaceuticals ...